Overview
Bipin Savani is a Hematologist Oncology specialist and a Transplant Surgeon in Nashville, Tennessee. Dr. Savani is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Leukemia, Bone Marrow Transplant, and Bone Graft. Dr. Savani is currently accepting new patients.
His clinical research consists of co-authoring 523 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Diffuse Large B-Cell Lymphoma (DLBCL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
3601 The Vanderbilt Clinic, Nashville, TN 37232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Tennessee Oncology PLLC
Ian Flinn is a Hematologist Oncology specialist and a Hematologist in Tullahoma, Tennessee. Dr. Flinn is rated as an Elite provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Flinn is currently accepting new patients.
Sarah Cannon Research Institute
Dr. Patel joined SCRI in 2024, as director of lymphoma research, and oversees SCRI’s comprehensive lymphoma clinical trial portfolio. Previously, he served as the Director of Hematologic Malignancies and Cell Therapy at the Swedish Cancer Institute in Seattle, Washington, where he led development of the program’s clinical standards for lymphoma care, assisted in the expansion of cell therapy services, and helped shape lymphoma research efforts. Dr. Patel was also a member of the Paul G. Allen Research Center at Seattle Cancer Institute, serving as a co-founding member of the Center for Immuno-oncology, where he collaborated on translational research related to immunotherapy in hematologic diseases.Dr. Patel has been published in various medical journals, including New England Journal of Medicine, Blood, and Journal of Clinical Oncology. He is also a member of the ASCO Cancer Communications Committee, the CIBMTR Lymphoma Working Committee, and the National Planning Committee for the Lymphoma Research Foundation Lymphoma Rounds. His clinical and research focus is in lymphomas, CLL, and cellular therapy. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Vanderbilt Health Clinicians, LLC
Nishitha Reddy is a Hematologist Oncology specialist and an Oncologist in Nashville, Tennessee. Dr. Reddy is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Small Lymphocytic Lymphoma (SLL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Reddy is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)
- Bone Marrow TransplantDr. Savani isElite. Learn about Bone Marrow Transplant.
- Graft Versus Host Disease (GvHD)
- LeukemiaDr. Savani isElite. Learn about Leukemia.
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Dr. Savani isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- Bone GraftDr. Savani isDistinguished. Learn about Bone Graft.
- Chronic Graft Versus Host Disease (cGvHD)Dr. Savani isDistinguished. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Multiple MyelomaDr. Savani isDistinguished. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Savani isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- AnemiaDr. Savani isAdvanced. Learn about Anemia.
- Aplastic AnemiaDr. Savani isAdvanced. Learn about Aplastic Anemia.
- B-Cell LymphomaDr. Savani isAdvanced. Learn about B-Cell Lymphoma.
- Childhood Acute Myeloid LeukemiaDr. Savani isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Experienced
- Acute Monoblastic Leukemia (AmoL)Dr. Savani isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Adult T-Cell LeukemiaDr. Savani isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Savani isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Savani isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Autoimmune Hemolytic AnemiaDr. Savani isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Cardiac AmyloidosisDr. Savani isExperienced. Learn about Cardiac Amyloidosis.